Benzinga's Top Ratings Upgrades, Downgrades For February 12, 2021

Upgrades

According to Citigroup, the prior rating for YETI Holdings Inc YETI was changed from Neutral to Buy. In the fourth quarter, YETI Holdings showed an EPS of $0.74, compared to $0.48 from the year-ago quarter. The stock has a 52-week-high of $80.89 and a 52-week-low of $15.28. At the end of the last trading period, YETI Holdings closed at $71.78.

According to Citigroup, the prior rating for Albemarle Corp ALB was changed from Neutral to Buy. In the third quarter, Albemarle showed an EPS of $1.09, compared to $1.53 from the year-ago quarter. The current stock performance of Albemarle shows a 52-week-high of $188.35 and a 52-week-low of $48.89. Moreover, at the end of the last trading period, the closing price was at $159.71.

Citigroup upgraded the previous rating for Sociedad Quimica Y Minera De Chile SA SQM from Neutral to Buy. Sociedad Quimica Y Minera earned $0.01 in the third quarter, compared to $0.23 in the year-ago quarter. The current stock performance of Sociedad Quimica Y Minera shows a 52-week-high of $60.74 and a 52-week-low of $15.20. Moreover, at the end of the last trading period, the closing price was at $54.29.

According to Benchmark, the prior rating for Amtech Systems Inc ASYS was changed from Hold to Buy. Amtech Systems earned $0.05 in the first quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of $8.95 and a 52-week-low of $3.55. At the end of the last trading period, Amtech Systems closed at $8.85.

For TransUnion TRU, Jefferies upgraded the previous rating of Hold to Buy. For the third quarter, TransUnion had an EPS of $0.81, compared to year-ago quarter EPS of $0.76. At the moment, the stock has a 52-week-high of $102.80 and a 52-week-low of $52.50. TransUnion closed at $92.27 at the end of the last trading period.

For Royal Dutch Shell PLC RDS, ScotiaBank upgraded the previous rating of Sector Underperform to Sector Perform. At the moment, the stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . Royal Dutch Shell closed at $37.32 at the end of the last trading period.

According to Baird, the prior rating for Vocera Communications Inc VCRA was changed from Neutral to Outperform. In the fourth quarter, Vocera Communications showed an EPS of $0.28, compared to $0.15 from the year-ago quarter. The current stock performance of Vocera Communications shows a 52-week-high of $49.18 and a 52-week-low of $15.89. Moreover, at the end of the last trading period, the closing price was at $42.03.

Mizuho upgraded the previous rating for HubSpot Inc HUBS from Neutral to Buy. For the fourth quarter, HubSpot had an EPS of $0.40, compared to year-ago quarter EPS of $0.45. The stock has a 52-week-high of $438.00 and a 52-week-low of $90.83. At the end of the last trading period, HubSpot closed at $431.15.

For Copart Inc CPRT, Stephens & Co. upgraded the previous rating of Equal-Weight to Overweight. Copart earned $0.79 in the first quarter, compared to $0.65 in the year-ago quarter. The stock has a 52-week-high of $130.96 and a 52-week-low of $55.69. At the end of the last trading period, Copart closed at $115.97.

Jefferies upgraded the previous rating for Prothena Corp PLC PRTA from Hold to Buy. In the fourth quarter, Prothena Corp showed an EPS of $0.77, compared to $0.54 from the year-ago quarter. The stock has a 52-week-high of $16.25 and a 52-week-low of $7.10. At the end of the last trading period, Prothena Corp closed at $15.70.

Raymond James upgraded the previous rating for HubSpot Inc HUBS from Outperform to Strong Buy. In the fourth quarter, HubSpot showed an EPS of $0.40, compared to $0.45 from the year-ago quarter. The current stock performance of HubSpot shows a 52-week-high of $438.00 and a 52-week-low of $90.83. Moreover, at the end of the last trading period, the closing price was at $431.15.

See all analyst ratings upgrades.

Downgrades

For CarGurus Inc CARG, DA Davidson downgraded the previous rating of Buy to Neutral. In the fourth quarter, CarGurus showed an EPS of $0.32, compared to $0.17 from the year-ago quarter. The current stock performance of CarGurus shows a 52-week-high of $36.54 and a 52-week-low of $14.25. Moreover, at the end of the last trading period, the closing price was at $34.73.

According to JP Morgan, the prior rating for Axon Enterprise Inc AXON was changed from Overweight to Neutral. For the third quarter, Axon Enterprise had an EPS of $0.40, compared to year-ago quarter EPS of $0.28. At the moment, the stock has a 52-week-high of $212.37 and a 52-week-low of $160.30. Axon Enterprise closed at $203.51 at the end of the last trading period.

Truist Securities downgraded the previous rating for Treehouse Foods Inc THS from Buy to Hold. For the fourth quarter, Treehouse Foods had an EPS of $1.07, compared to year-ago quarter EPS of $1.10. The current stock performance of Treehouse Foods shows a 52-week-high of $53.98 and a 52-week-low of $33.50. Moreover, at the end of the last trading period, the closing price was at $49.40.

According to Truist Securities, the prior rating for Limelight Networks Inc LLNW was changed from Buy to Hold. Limelight Networks earned $0.03 in the fourth quarter, compared to $0.05 in the year-ago quarter. The stock has a 52-week-high of $8.19 and a 52-week-low of $3.43. At the end of the last trading period, Limelight Networks closed at $4.56.

Citigroup downgraded the previous rating for Children's Place Inc PLCE from Neutral to Sell. In the third quarter, Children's Place showed an EPS of $1.44, compared to $3.03 from the year-ago quarter. The stock has a 52-week-high of $79.03 and a 52-week-low of $9.25. At the end of the last trading period, Children's Place closed at $76.26.

For Treehouse Foods Inc THS, Credit Suisse downgraded the previous rating of Outperform to Neutral. In the fourth quarter, Treehouse Foods showed an EPS of $1.07, compared to $1.10 from the year-ago quarter. At the moment, the stock has a 52-week-high of $53.98 and a 52-week-low of $33.50. Treehouse Foods closed at $49.40 at the end of the last trading period.

For Hyatt Hotels Corp H, Berenberg downgraded the previous rating of Hold to Sell. Hyatt Hotels earned $1.48 in the third quarter, compared to $0.37 in the year-ago quarter. At the moment, the stock has a 52-week-high of $94.98 and a 52-week-low of $24.02. Hyatt Hotels closed at $73.97 at the end of the last trading period.

For Norwegian Cruise Line Holdings Ltd NCLH, Berenberg downgraded the previous rating of Buy to Hold. For the third quarter, Norwegian Cruise Line had an EPS of $2.35, compared to year-ago quarter EPS of $2.23. The current stock performance of Norwegian Cruise Line shows a 52-week-high of $54.28 and a 52-week-low of $7.03. Moreover, at the end of the last trading period, the closing price was at $23.79.

Berenberg downgraded the previous rating for Royal Caribbean Group RCL from Hold to Sell. For the third quarter, Royal Caribbean Group had an EPS of $5.62, compared to year-ago quarter EPS of $4.27. The current stock performance of Royal Caribbean Group shows a 52-week-high of $118.03 and a 52-week-low of $19.25. Moreover, at the end of the last trading period, the closing price was at $67.89.

Berenberg downgraded the previous rating for Carnival Corp CCL from Hold to Sell. Carnival earned $2.02 in the fourth quarter, compared to $0.62 in the year-ago quarter. The stock has a 52-week-high of $44.44 and a 52-week-low of $7.80. At the end of the last trading period, Carnival closed at $20.73.

According to Jefferies, the prior rating for Esperion Therapeutics Inc ESPR was changed from Buy to Hold. In the third quarter, Esperion Therapeutics showed an EPS of $3.07, compared to $2.52 from the year-ago quarter. At the moment, the stock has a 52-week-high of $76.98 and a 52-week-low of $23.90. Esperion Therapeutics closed at $30.74 at the end of the last trading period.

For Ultragenyx Pharmaceutical Inc RARE, JP Morgan downgraded the previous rating of Overweight to Neutral. Ultragenyx Pharmaceutical earned $0.37 in the fourth quarter, compared to $1.62 in the year-ago quarter. The current stock performance of Ultragenyx Pharmaceutical shows a 52-week-high of $179.65 and a 52-week-low of $31.99. Moreover, at the end of the last trading period, the closing price was at $162.78.

Barclays downgraded the previous rating for Iridium Communications Inc IRDM from Overweight to Underweight. Iridium Communications earned $0.06 in the fourth quarter, compared to $0.82 in the year-ago quarter. The current stock performance of Iridium Communications shows a 52-week-high of $54.65 and a 52-week-low of $16.87. Moreover, at the end of the last trading period, the closing price was at $46.11.

For Williams-Sonoma Inc WSM, Oppenheimer downgraded the previous rating of Outperform to Perform. Williams-Sonoma earned $2.56 in the third quarter, compared to $1.02 in the year-ago quarter. The stock has a 52-week-high of $151.16 and a 52-week-low of $26.01. At the end of the last trading period, Williams-Sonoma closed at $127.65.

Raymond James downgraded the previous rating for Limelight Networks Inc LLNW from Outperform to Market Perform. Limelight Networks earned $0.03 in the fourth quarter, compared to $0.05 in the year-ago quarter. The current stock performance of Limelight Networks shows a 52-week-high of $8.19 and a 52-week-low of $3.43. Moreover, at the end of the last trading period, the closing price was at $4.56.

SVB Leerink downgraded the previous rating for Amicus Therapeutics Inc FOLD from Outperform to Market Perform. Amicus Therapeutics earned $0.22 in the third quarter, compared to $0.24 in the year-ago quarter. The current stock performance of Amicus Therapeutics shows a 52-week-high of $25.39 and a 52-week-low of $6.25. Moreover, at the end of the last trading period, the closing price was at $18.73.

For Amicus Therapeutics Inc FOLD, JP Morgan downgraded the previous rating of Overweight to Neutral. For the third quarter, Amicus Therapeutics had an EPS of $0.22, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $25.39 and a 52-week-low of $6.25. At the end of the last trading period, Amicus Therapeutics closed at $18.73.

DA Davidson downgraded the previous rating for NIC Inc EGOV from Buy to Neutral. NIC earned $0.26 in the fourth quarter, compared to $0.13 in the year-ago quarter. The stock has a 52-week-high of $35.32 and a 52-week-low of $15.49. At the end of the last trading period, NIC closed at $34.56.

See all analyst ratings downgrades.

Initiations

Ladenburg Thalmann initiated coverage on Artelo Biosciences Inc ARTL with a Buy rating. The price target for Artelo Biosciences is set to $7.00. In the first quarter, Artelo Biosciences showed an EPS of $0.14, compared to $0.40 from the year-ago quarter. At the moment, the stock has a 52-week-high of $2.13 and a 52-week-low of $0.45. Artelo Biosciences closed at $1.63 at the end of the last trading period.

With an Overweight rating, Piper Sandler initiated coverage on Orange County Bancorp Inc OCBI. The price target seems to have been set at $35.00 for Orange County Bancorp. At the moment, the stock has a 52-week-high of $27.50 and a 52-week-low of $22.00. Orange County Bancorp closed at $28.00 at the end of the last trading period.

Piper Sandler initiated coverage on Hims & Hers Health Inc HIMS with a Neutral rating. The price target for Hims & Hers Health is set to $20.00. The stock has a 52-week-high of $25.40 and a 52-week-low of $13.00. At the end of the last trading period, Hims & Hers Health closed at $21.36.

Morgan Stanley initiated coverage on Lordstown Motors Corp RIDE with an Underweight rating. The price target for Lordstown Motors is set to $18.00. In the third quarter, Lordstown Motors showed an EPS of $0.00, compared to $0.01 from the year-ago quarter. At the moment, the stock has a 52-week-high of $31.57 and a 52-week-low of $12.80. Lordstown Motors closed at $30.75 at the end of the last trading period.

With an Underweight rating, Morgan Stanley initiated coverage on Romeo Power Inc RMO. The price target seems to have been set at $12.00 for Romeo Power. At the moment, the stock has a 52-week-high of $32.73 and a 52-week-low of $17.06. Romeo Power closed at $17.64 at the end of the last trading period.

Morgan Stanley initiated coverage on QuantumScape Corp QS with an Overweight rating. The price target for QuantumScape is set to $70.00. The stock has a 52-week-high of $132.73 and a 52-week-low of $28.63. At the end of the last trading period, QuantumScape closed at $44.94.

With an Overweight rating, Morgan Stanley initiated coverage on Fisker Inc FSR. The price target seems to have been set at $27.00 for Fisker. The stock has a 52-week-high of $23.62 and a 52-week-low of $14.32. At the end of the last trading period, Fisker closed at $15.42.

With an Outperform rating, Oppenheimer initiated coverage on Inovio Pharmaceuticals Inc INO. The price target seems to have been set at $35.00 for Inovio Pharmaceuticals. For the third quarter, Inovio Pharmaceuticals had an EPS of $0.26, compared to year-ago quarter EPS of $0.25. The current stock performance of Inovio Pharmaceuticals shows a 52-week-high of $33.79 and a 52-week-low of $3.26. Moreover, at the end of the last trading period, the closing price was at $13.00.

With a Buy rating, Jefferies initiated coverage on Global Ship Lease Inc GSL. The price target seems to have been set at $18.00 for Global Ship Lease. In the third quarter, Global Ship Lease showed an EPS of $0.77, compared to $0.43 from the year-ago quarter. The current stock performance of Global Ship Lease shows a 52-week-high of $17.69 and a 52-week-low of $2.61. Moreover, at the end of the last trading period, the closing price was at $12.86.

For LeMaitre Vascular Inc LMAT, KeyBanc initiated coverage, by setting the current rating at Sector Weight. For the third quarter, LeMaitre Vascular had an EPS of $0.37, compared to year-ago quarter EPS of $0.25. The stock has a 52-week-high of $50.53 and a 52-week-low of $18.76. At the end of the last trading period, LeMaitre Vascular closed at $47.53.

See all analyst ratings initiations.